BridgeMD
New treatment option for Congenital Heart Disease in Adolescence
Official title The Effect of Structured Transition Care Model Applied to Adolescents With Congenital Heart Disease
ClinicalTrials.gov ID: NCT06433401
What this study is testing
- What it's testing
- Congenital heart disease is one of the most common congenital defects with a high mortality and morbidity rate. Children with congenital heart disease step from pediatric care to adult care during adolescence.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 to 20
You may be able to join if
- Voluntarily agree to participate in the research
- To be between the ages of 16-20,
- Having a diagnosis of congenital heart disease,
- Being followed up with a diagnosis of congenital heart disease for at least one year in the polyclinics where the study was conducted,
- To be able to communicate in Turkish,
You likely can't join if
- Refusing to participate in the research,
- Not being able to communicate in Turkish,
- Not showing up regularly for follow-ups,
- Having any mental disability that may prevent communication
See the full eligibility criteria
- Voluntarily agree to participate in the research
- To be between the ages of 16-20,
- Having a diagnosis of congenital heart disease,
- Being followed up with a diagnosis of congenital heart disease for at least one year in the polyclinics where the study was conducted,
- To be able to communicate in Turkish,
- Not having any mental deficiency that may prevent communication
- Refusing to participate in the research,
- Not being able to communicate in Turkish,
- Not showing up regularly for follow-ups,
- Having any mental disability that may prevent communication
The study team makes the final eligibility decision.
Where it's taking place
- Ankara, Ankara Yenimahalle, Turkey (Türkiye)
- Ankara, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years to 20 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ankara, Ankara Yenimahalle, Turkey (Türkiye); Ankara, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.